DTAN - ETF AI Analysis
Top Page
Sparkline International Intangible Value ETF (DTAN)
DTAN, the Sparkline International Intangible Value ETF, has a solid overall rating driven mainly by strong, diversified holdings like Novartis and Toyota, which show robust financial health, positive earnings sentiment, and supportive technical trends. Other major positions such as Roche, Siemens, Hitachi, Sony, and Sanofi also add quality, though several holdings face potential overvaluation or short-term technical weakness, creating some risk from market pullbacks rather than from concentration in any single sector or region.
DTAN vs. SPDR S&P 500 ETF (SPY)
- AUM
- 22.03M
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.55%
- Beta
- 0.78
- Issuer
- Sparkline
- Inception Date
- Sep 09, 2024
- Dividend Yield
- 1.89%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DTAN Summary
Sparkline International Intangible Value ETF (DTAN) is a global stock fund that focuses on companies whose value comes largely from things you can’t touch, like strong brands, patents, and innovation. It doesn’t track a specific index, but follows a theme of “intangible value” across many countries and sectors. Well-known holdings include Toyota, Sony, L’Oreal, Roche, and Novartis, giving investors broad international diversification with a tilt toward established, high-quality businesses. Someone might invest for long-term growth and global exposure. A key risk is that the share price can rise or fall with global stock markets, and the fund’s unique strategy may underperform traditional index funds at times.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 invested. That’s higher than the average index ETF because DTAN is actively managed and focuses on a specialized strategy around intangible value in international companies.
What would affect this ETF?
DTAN could benefit if global growth outside the U.S. improves and companies with strong brands, patents, and innovation—like its major health care, technology, and industrial holdings in Europe and Japan—continue to gain value as intangible assets become more important. On the downside, weaker international economies, currency swings, higher interest rates that pressure value stocks, or new regulations affecting big drug, tech, and energy companies could hurt the ETF’s future performance.
DTAN Top 10 Holdings
DTAN leans heavily on European and Japanese blue chips, with health care and industrial names setting the tone. Roche and Novartis have been steady long-term contributors, even if their recent momentum has cooled. Siemens and Hitachi are more like the fund’s growth engines, rising on solid earnings and industrial strength. On the flip side, SAP and Sony have been losing steam, and Sanofi is clearly lagging, acting as a drag on performance. Overall, it’s a global ex‑U.S. mix anchored in intangible-rich brands and innovators.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 3.32% | $732.18K | CHF 236.54B | 30.70% | 80Outperform |
 DE:SAP | SAP SE | 3.15% | $694.76K | EUR 246.59B | -9.78% | 66Neutral |
 DE:SIE | Siemens | 3.18% | $700.49K | EUR 205.85B | 9.66% | 74Outperform |
 FR:OR | L'Oreal | 2.90% | $637.97K | EUR 225.36B | 14.36% | 71Outperform |
 JP:7203 | Toyota Motor | 2.90% | $637.70K | JPY 36.13T | -3.78% | 80Outperform |
 JP:6758 | Sony | 2.50% | $550.79K | JPY 23.45T | -9.55% | 73Outperform |
 GB:SHEL | Shell (UK) | 2.42% | $532.03K | GBP 224.83B | 39.66% | 73Outperform |
 JP:6501 | Hitachi,Ltd. | 2.25% | $495.07K | JPY 25.41T | 20.14% | 77Outperform |
 GB:GSK | GlaxoSmithKline | 2.25% | $495.77K | GBP 73.42B | 11.41% | 77Outperform |
DTAN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DTAN, the sentiment is Positive. The current price of 33.94 is above the 20-day moving average (MA) of 33.16, above the 50-day MA of 33.42, and above the 200-day MA of 32.15, indicating a bullish trend. The MACD of 0.25 indicates Negative momentum. The RSI at 61.33 is Neutral, neither overbought nor oversold. The STOCH value of 82.63 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DTAN.
DTAN Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DTAN | $33.94 | $35.00(3.13% Upside) | $22.03M | 0.55% | 67Neutral |
 GIEQ | $41.26 | $49.09(18.97% Upside) | $59.46M | 0.30% | 66Neutral |
 PJIO | $59.54 | $80.13(34.59% Upside) | $57.76M | 0.54% | 64Neutral |
 AADR | $81.22 | $96.62(18.97% Upside) | $35.68M | 1.09% | 69Neutral |
 MIVL | $25.66 | $30.17(17.59% Upside) | $22.33M | 0.57% | 68Neutral |
 PZIV | $29.95 | $33.03(10.27% Upside) | $17.12M | 0.70% | 59Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DTAN | Sparkline International Intangible Value ETF | 33.94 | 4.14 | 13.91% | |
| GIEQ | Goldman Sachs Data Enhanced International Equity ETF | 41.26 | 0.77 | 1.89% | |
| PJIO | PGIM Jennison International Opportunities ETF | 59.54 | -4.43 | -6.93% | |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 81.22 | -2.66 | -3.17% | |
| MIVL | MFS Active International Value ETF | 25.66 | 0.38 | 1.49% | |
| PZIV | Pzena International Value ETF | 29.95 | 4.37 | 17.07% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.